| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966269 | Vaccine | 2013 | 9 Pages |
Abstract
Our approach incorporates financial risk protection and distributional consequences into the systematic economic evaluation of vaccine policy, illustrated here with the case study of public finance for rotavirus vaccination. This enables selection of vaccine packages based on the quantitative inclusion of information on equity and on how much financial risk protection is being bought per dollar expenditure on vaccine policy, in addition to how much health is being bought.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stéphane Verguet, Shane Murphy, Benjamin Anderson, Kjell Arne Johansson, Roger Glass, Richard Rheingans,